Vor Biopharma
Dallan Murray currently serves as Executive Vice President and Chief Commercial Officer at Vor Bio since August 2025. Previously, Dallan held several senior roles at Sarepta Therapeutics, including Executive Vice President and Chief Customer Officer, and Vice President of Commercial Strategy and Portfolio Management, where oversight included U.S. commercial positioning for a pipeline of over 40 investigational therapies. Dallan also led the launch of two successful rare disease therapies as Vice President of Marketing. Earlier experience includes leadership positions in marketing and strategy at Vertex Pharmaceuticals, Gilead Sciences, Biogen Idec, and Janssen-Ortho, contributing to notable product launches and commercial strategies. Dallan holds an MBA from Queen's University and a Bachelor of Commerce from the University of Alberta.
This person is not in any teams
This person is not in any offices
Vor Biopharma
3 followers
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer. It is focused on developing technologies that can enable selective targeting of cancer cells without impacting normal cells.